(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...

If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

The stock market's "Trump bump" that followed his victory over Vice President Kamala Harris in last week's election appears ...

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...

Shares of Novavax Inc. NVAX rose 1.39% to $7.32 Friday, on what proved to be an all-around rough trading session for the ...

Pfizer stock and shares of other vaccine makers slumped Friday after President-elect Donald Trump tapped Robert F. Kennedy Jr ...

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX ...

The stocks for three pharmaceutical companies heavily involved in the production of vaccines fell drastically by market close ...

Find the latest Trump Transition news from Fast company. See related business and technology articles, photos, slideshows and ...

Shares of COVID vaccine manufacturers Moderna and Pfizer fell early Friday morning, down 4% and 4.3% respectively.

Robert F. Kennedy Jr.'s chance to head the Department of Health and Human Services vexes Jake Tapper: "I hope you like ...